Journey Medical Corp | Micro-cap | Healthcare
$7.30
0.69%
| Journey Medical Stock Comparison:
Journey Medical vs Haleon Plc - ADRJourney Medical vs United TherapeuticsJourney Medical vs IronwoodJourney Medical vs BioAge LabsJourney Medical vs China SXTJourney Medical vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 15.0M
Gross Profit 10.1M 67.09%
Operating Income -2.9M -19.16%
Net Income -3.8M -25.29%
EPS (Diluted) $-0.16

Balance Sheet Metrics

Total Assets 85.0M
Total Liabilities 63.4M
Shareholders Equity 21.5M
Debt to Equity 2.94

Cash Flow Metrics

Operating Cash Flow -9.3M
Free Cash Flow -2.8M

Revenue & Profitability Trend

Journey Medical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i56.1M79.2M73.7M63.1M44.5M
Cost of Goods Sold i20.9M26.7M30.8M32.1M14.6M
Gross Profit i35.3M52.5M42.9M31.0M29.9M
Gross Margin % i62.8%66.3%58.2%49.2%67.2%
Operating Expenses
Research & Development i9.9M7.5M10.9M16.6M0
Selling, General & Administrative i40.2M43.9M59.5M39.8M22.1M
Other Operating Expenses i-----
Total Operating Expenses i50.1M51.5M70.4M56.4M22.1M
Operating Income i-18.2M1.1M-27.5M-25.3M7.9M
Operating Margin % i-32.5%1.4%-37.4%-40.1%17.6%
Non-Operating Items
Interest Income i757.0K322.0K60.0K2.0K0
Interest Expense i2.7M1.7M2.0M7.0M698.0K
Other Non-Operating Income5.6M-3.3M-89.0K-10.0M-
Pre-tax Income i-14.6M-3.6M-29.6M-42.4M7.2M
Income Tax i61.0K221.0K63.0K1.6M1.9M
Effective Tax Rate % i0.0%0.0%0.0%0.0%26.1%
Net Income i-14.7M-3.9M-29.6M-44.0M5.3M
Net Margin % i-26.1%-4.9%-40.2%-69.7%11.9%
Key Metrics
EBITDA i-14.0M5.2M-23.1M-22.8M9.4M
EPS (Basic) i$-0.72$-0.21$-1.69$-4.32$0.58
EPS (Diluted) i$-0.72$-0.21$-1.69$-4.32$0.58
Basic Shares Outstanding i204314001823242217531274101898449160344
Diluted Shares Outstanding i204314001823242217531274101898449160344

Income Statement Trend

Journey Medical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i20.3M27.4M32.0M49.1M8.2M
Short-term Investments i-----
Accounts Receivable i10.2M15.2M28.2M23.1M23.9M
Inventory i14.4M10.2M14.2M9.9M1.4M
Other Current Assets3.2M3.6M3.3M2.4M1.7M
Total Current Assets i48.2M56.5M77.7M84.5M35.2M
Non-Current Assets
Property, Plant & Equipment i199.0K101.0K189.0K89.0K175.0K
Goodwill i31.9M20.3M27.2M12.6M15.0M
Intangible Assets i31.9M20.3M27.2M12.6M15.0M
Long-term Investments-----
Other Non-Current Assets-6.0K95.0K150.0K1.5M
Total Non-Current Assets i32.1M20.4M27.5M12.8M16.7M
Total Assets i80.2M76.8M105.2M97.3M51.9M
Liabilities
Current Liabilities
Accounts Payable i16.0M18.3M37.0M23.5M2.0M
Short-term Debt i83.0K99.0K3.0M910.0K85.0K
Current Portion of Long-term Debt-----
Other Current Liabilities625.0K3.2M2.8M5.0M5.8M
Total Current Liabilities i35.2M41.9M66.8M51.6M28.1M
Non-Current Liabilities
Long-term Debt i25.0M14.6M19.9M05.3M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities--1.4M3.6M8.1M
Total Non-Current Liabilities i25.0M14.6M21.3M3.6M13.6M
Total Liabilities i60.2M56.5M88.2M55.2M41.6M
Equity
Common Stock i2.0K2.0K2.0K2.0K1.0K
Retained Earnings i-87.0M-72.4M-68.5M-38.9M5.1M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i20.1M20.4M17.0M42.0M10.3M
Key Metrics
Total Debt i25.1M14.7M23.0M910.0K5.4M
Working Capital i13.0M14.6M10.8M32.9M7.2M

Balance Sheet Composition

Journey Medical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-14.7M-3.9M-29.6M-44.0M5.3M
Depreciation & Amortization i3.5M3.9M4.4M2.6M1.5M
Stock-Based Compensation i6.1M2.6M4.4M2.5M153.0K
Working Capital Changes i-1.9M-2.0M10.7M12.5M-5.8M
Operating Cash Flow i-6.7M1.3M-9.3M-4.9M1.5M
Investing Activities
Capital Expenditures i-----
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i---20.0M--
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i17.9M15.0M19.8M9.5M0
Debt Repayment i-1.2M-51.9M-7.9M-11.5M-500.0K
Financing Cash Flow i16.6M-35.9M13.4M46.8M-500.0K
Free Cash Flow i-24.1M240.0K-33.5M-12.2M3.9M
Net Change in Cash i9.9M-34.6M-15.9M41.9M1.0M

Cash Flow Trend

Journey Medical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 39.08
Forward P/E -118.33
Price to Book 8.66
Price to Sales 3.31
PEG Ratio -6.64

Profitability Ratios

Profit Margin -15.49%
Operating Margin -19.16%
Return on Equity -57.22%
Return on Assets -5.86%

Financial Health

Current Ratio 1.27
Debt to Equity 131.34
Beta 0.81

Per Share Data

EPS (TTM) $-0.37
Book Value per Share $0.82
Revenue per Share $2.57

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
derm186.8M39.088.66-57.22%-15.49%131.34
Haleon Plc - ADR 41.7B19.935.089.38%13.81%53.41
United Therapeutics 19.3B16.922.6819.30%40.36%0.00
Ironwood 230.7M92.69-0.73-0.29%-2.56%-1.94
BioAge Labs 212.2M-0.890.72-35.88%0.00%2.97
China SXT 183.3M0.011.44-22.50%-189.77%6.37

Financial data is updated regularly. All figures are in the company's reporting currency.